| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/21/2010 | US20100015089 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 01/21/2010 | US20100015087 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 01/21/2010 | US20100015055 Pretreatment of a biological sample from an autoimmune disease subject |
| 01/21/2010 | US20100015048 Internalizing Anti-CD74 Antibodies and Methods of Use |
| 01/21/2010 | CA2731218A1 Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome |
| 01/21/2010 | CA2731194A1 Chimeric respiratory syncytial virus polypeptide antigens |
| 01/21/2010 | CA2730959A1 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | CA2730796A1 Aptamer against il-17 and use thereof |
| 01/21/2010 | CA2730674A1 Treatment of inflammatory diseases with mammal beta defensins |
| 01/21/2010 | CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 01/21/2010 | CA2730063A1 Compositions and methods of use for therapeutic antibodies |
| 01/21/2010 | CA2728311A1 Aminotetrahydroindazoloacetic acids |
| 01/21/2010 | CA2728094A1 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 01/21/2010 | CA2726460A1 Novel phenyl-imidazopyridines and pyridazines |
| 01/21/2010 | CA2725512A1 Novel phenylimidazopyrazines |
| 01/20/2010 | EP2145961A2 Porcine adenovirus type 3 genome |
| 01/20/2010 | EP2145958A1 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 01/20/2010 | EP2145887A2 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and use thereof |
| 01/20/2010 | EP2144932A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 01/20/2010 | EP2144930A1 Single chain fc, methods of making and methods of treatment |
| 01/20/2010 | EP1599227B1 Methods of immunomodulation in animals |
| 01/20/2010 | EP1456160B1 Vitamin d analogues |
| 01/20/2010 | EP1427396B1 Dosage forms having prolonged active ingredient release |
| 01/20/2010 | EP1077994B1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 01/20/2010 | CN100582102C Process for preparing methylation catechin by tea |
| 01/20/2010 | CN100582084C Hydrophobic polyamine analogs and methods for their use |
| 01/20/2010 | CN100581555C Viable prebiotics bacteria microcapsule preparations for livestock and method for preparing the same |
| 01/20/2010 | CN100581545C Siromosi medicinal composition and its making method |
| 01/19/2010 | US7649095 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 01/19/2010 | US7649008 Crystal of 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid; has chymase inhibitory activity in living body and can be used as a preventive and/or remedy for inflammatory diseases, allergic diseases, respiratory tract diseases, circulatory diseases, or bone metabolic diseases |
| 01/19/2010 | US7648997 Immunomodulators for inducing cytokine biosynthesis, for treatment of diseases including viral and neoplastic diseases; 1-[3-(Aminooxy)propyl]-2-propyl-1H-imidazo[4,5-c]quinolin-4-amine; N-[3-(4-Amino-2-propyl-1H-imidazo[4,5-c]quinolin-1-yl)propoxy]cyclopropanecarboxamide |
| 01/19/2010 | US7648971 Thrombopoietin mimetics |
| 01/19/2010 | US7648707 Compositions and methods for treatment of microbial infections |
| 01/19/2010 | US7648702 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine. |
| 01/19/2010 | US7648701 Peptide composition as immunogen for the treatment of allergy |
| 01/19/2010 | CA2420026C 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 01/19/2010 | CA2413000C Five-membered ring compounds |
| 01/19/2010 | CA2335107C Leptin-mediated gene-induction |
| 01/19/2010 | CA2239904C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/14/2010 | WO2010006326A2 Methods and compositions for spore-based vaccines |
| 01/14/2010 | WO2010006172A2 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | WO2010006169A2 2-methylene-19, 26-dinor-(20s, 22e, 25r)-vitamin d analogs |
| 01/14/2010 | WO2010006135A2 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 01/14/2010 | WO2010006125A2 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs |
| 01/14/2010 | WO2010006123A2 19-nor-vitamin d analogs with 1,2-dihydrofuran ring |
| 01/14/2010 | WO2010006121A2 19-nor-vitamin d analogs with 3,2-dihydrofuran ring |
| 01/14/2010 | WO2010005958A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | WO2010005069A1 Immunity-inducing agent and method for detection of cancer |
| 01/14/2010 | WO2010004816A1 Inhibitor of degranulation of mast cell |
| 01/14/2010 | WO2010004304A1 Novel compounds and methods for their production |
| 01/14/2010 | WO2010004197A2 Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof |
| 01/14/2010 | WO2010003240A1 Gmcsf and truncated ccl2 conjugates and methods and uses thereof |
| 01/14/2010 | WO2010003219A1 Compositions comprising salmonella porins and uses thereof as adjuvants and vaccines |
| 01/14/2010 | WO2010003193A1 Peptide inhibitors of cd40l signaling and uses therefor |
| 01/14/2010 | WO2009141434A4 Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant |
| 01/14/2010 | WO2009140754A8 An anti-cancer cytotoxic monoclonal antibody |
| 01/14/2010 | WO2009126737A3 Triterpene saponins, methods of synthesis, and uses thereof |
| 01/14/2010 | WO2009117150A3 Method of treating lupus with ceramide derivatives |
| 01/14/2010 | WO2009052090A3 Silicate containing compositions and methods of treatment |
| 01/14/2010 | US20100010229 Fexofenadine polymorph |
| 01/14/2010 | US20100010227 Process for production of piperidine derivatives |
| 01/14/2010 | US20100010207 Rna interference mediating small rna molecules |
| 01/14/2010 | US20100010195 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 01/14/2010 | US20100010053 3-[7-(5-{3-Chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-yl]propanoic acid; multiple sclerosis, autoimmune diseases, chronic inflammatory disorders, asthma, inflammatory neuropathies, arthritis, transplantation, Crohn's disease, ulcerative colitis, lupus erythematosis, psoriasis |
| 01/14/2010 | US20100010020 Phosphodiesterase 4 inhibitors |
| 01/14/2010 | US20100010008 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100010000 Amino alcohol derivative and immunosuppresive agent having same as an active ingredient |
| 01/14/2010 | US20100009999 Alkyl substituted indoloquinoxalines |
| 01/14/2010 | US20100009991 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009951 Ciclesonide containing sterile aqueous suspension |
| 01/14/2010 | US20100009946 2-Methylene-19,26-Dinor-(20R,22E,25R)-Vitamin D Analogs |
| 01/14/2010 | US20100009945 3,2-dihydrofuran-1 alpha ,25-dihydroxy-19-nor-vitamin D3; prophylaxis of autoimmune diseases, some types of cancers, metabolic bone diseases, osteomalacia, osteopenia, secondary hyperparathyroidism, psoriasis, or other skin diseases; osteoporosis |
| 01/14/2010 | US20100009944 19-Nor-Vitamin D Analogs with 1,2-Dihydrofuran Ring |
| 01/14/2010 | US20100009941 2-Methylene-20(21)-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | US20100009927 Anti-Inflammatory and Anti-Allergy Extracts from Nettle |
| 01/14/2010 | US20100009902 Glycoconjugation Using Saccharyl Fragments |
| 01/14/2010 | US20100008984 Solid dispersions comprising tacrolimus |
| 01/14/2010 | US20100008951 Flu vaccine admixture of mannan and flu antigen |
| 01/14/2010 | US20100008949 Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic escherichia coli |
| 01/14/2010 | US20100008942 Histophilus Somni Polynucleotides, Polypeptides and Methods of Use |
| 01/14/2010 | US20100008940 Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response |
| 01/14/2010 | US20100008934 Genetic polymorphisms associated with autoinflammatory diseases, methods of detection and uses thereof |
| 01/14/2010 | US20100008931 Coronin 1 Modulators for the Treatment of Autoimmune and Lymphoproliferative Disorders and Mycobacterial Infections |
| 01/14/2010 | US20100008920 Reagents and Methods for Engaging Unique Clonotypic Lymphocyte Receptors |
| 01/14/2010 | US20100008915 Methods for treating disease using an anti-il-21 receptor antibody |
| 01/14/2010 | US20100008900 Annexin ii compositions for treating or monitoring inflammation or immune-mediated disorders |
| 01/14/2010 | CA2743975A1 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | CA2730408A1 Influenza hemagglutinin and neuraminidase variants |
| 01/14/2010 | CA2730257A1 2-methylene-19,26-dinor-(20s,22e,25r)-vitamin d analogs |
| 01/14/2010 | CA2730254A1 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 01/14/2010 | CA2730248A1 2-methylene-(20e)-20(22)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | CA2730247A1 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | CA2730244A1 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs |
| 01/14/2010 | CA2730088A1 Immunity-inducing agent and method for detection of cancer |
| 01/14/2010 | CA2729948A1 Tacrolimus for improved treatment of transplant patients |
| 01/14/2010 | CA2729833A1 Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof |
| 01/14/2010 | CA2729633A1 Tumor-initiating cells and methods of use |
| 01/14/2010 | CA2729351A1 Fn14/trail fusion proteins |